Literature DB >> 19539332

Age at orchiopexy and testis palpability predict germ and Leydig cell loss: clinical predictors of adverse histological features of cryptorchidism.

Gregory E Tasian1, Adam B Hittelman, Grace E Kim, Michael J DiSandro, Laurence S Baskin.   

Abstract

PURPOSE: We determined the relationship between clinical variables and testicular histopathological changes associated with decreased fertility potential in children with cryptorchidism.
MATERIALS AND METHODS: Testis biopsies of 274 children who underwent orchiopexy and concurrent testicular biopsy between 1991 and 2001 were analyzed for germ and Leydig cell loss, and testicular fibrosis. Multivariable logistic regression was used to determine if age at orchiopexy (analyzed as continuous and ordinal variables), preoperative testis palpability, unilateral vs bilateral disease and/or side of undescended testis was predictive of these pathological outcomes.
RESULTS: Age at orchiopexy was associated with germ and Leydig cell depletion. Each month of testis undescent was associated with development of moderate/severe germ cell depletion (OR 1.02 for each month of age, p <0.005) and Leydig cell loss (OR 1.01 for each month of age, p <0.02). Nonpalpable testes were associated with severe germ cell depletion. Children with palpable testes had lower odds of germ cell depletion than those with nonpalpable testes (OR 0.46, p <0.005). This finding corresponds to a significant 2% risk per month of severe germ cell loss and 1% risk per month of Leydig cell depletion for each month a testis remains undescended, and a 50% greater risk of germ cell depletion in nonpalpable relative to palpable cryptorchid testes.
CONCLUSIONS: Testes that remain undescended are associated with progressive loss of germ and Leydig cells, and nonpalpable testes predict severe germ cell loss.

Entities:  

Mesh:

Year:  2009        PMID: 19539332     DOI: 10.1016/j.juro.2009.04.032

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  37 in total

Review 1.  Ideal timing of orchiopexy: a systematic review.

Authors:  Emily Chan; Carolyn Wayne; Ahmed Nasr
Journal:  Pediatr Surg Int       Date:  2014-01       Impact factor: 1.827

2.  Cryptorchidism and its impact on male fertility: a state of art review of current literature.

Authors:  Eric Chung; Gerald B Brock
Journal:  Can Urol Assoc J       Date:  2011-06       Impact factor: 1.862

3.  Delayed treatment of undescended testes may promote hypogonadism and infertility.

Authors:  Julia Rohayem; Alessandra Luberto; Eberhard Nieschlag; Michael Zitzmann; Sabine Kliesch
Journal:  Endocrine       Date:  2017-01-09       Impact factor: 3.633

Review 4.  Surgical approach to the palpable undescended testis.

Authors:  Reju J Thomas; Andrew J A Holland
Journal:  Pediatr Surg Int       Date:  2014-05-29       Impact factor: 1.827

5.  A four-month-old boy with bilateral undescended testes.

Authors:  Sumit Dave
Journal:  CMAJ       Date:  2016-05-16       Impact factor: 8.262

Review 6.  [Cryptorchidism and fertility].

Authors:  I Rübben
Journal:  Urologe A       Date:  2016-07       Impact factor: 0.639

Review 7.  Presence of viable germ cells in testicular regression syndrome remnants: Is routine excision indicated? A systematic review.

Authors:  Ramesh Mark Nataraja; Evie Yeap; Costa J Healy; Inderpal S Nandhra; Feilim L Murphy; John M Hutson; Chris Kimber
Journal:  Pediatr Surg Int       Date:  2017-11-09       Impact factor: 1.827

8.  Canadian Urological Association-Pediatric Urologists of Canada (CUA-PUC) guideline for the diagnosis, management, and followup of cryptorchidism.

Authors:  Luis H Braga; Armando J Lorenzo; Rodrigo L P Romao
Journal:  Can Urol Assoc J       Date:  2017-07-11       Impact factor: 1.862

9.  Case of newly diagnosed bilateral anorchia in a 42-year-old male patient.

Authors:  Francisco Sousa Santos; Cátia Ferrinho; Clotilde Limbert; Carlos Vasconcelos
Journal:  BMJ Case Rep       Date:  2018-10-12

10.  Post-operative use of human chorionic gonadotrophin (u-hCG) inpatients treated for intrabdominal unilateral undescended testes.

Authors:  Nicola Zampieri; Virginia Murri; Francesco Saverio Camoglio
Journal:  Am J Clin Exp Urol       Date:  2018-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.